How Long Are Reperfusion Therapies Beneficial for Patients after Stroke Onset? Lessons from Lethal Ischemia Following Early Reperfusion in a Mouse Model of Stroke.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
02 Sep 2020
Historique:
received: 06 08 2020
revised: 28 08 2020
accepted: 31 08 2020
entrez: 5 9 2020
pubmed: 6 9 2020
medline: 26 3 2021
Statut: epublish

Résumé

Ischemic stroke caused by cerebral artery occlusion induces neurological deficits because of cell damage or death in the central nervous system. Given the recent therapeutic advances in reperfusion therapies, some patients can now recover from an ischemic stroke with no sequelae. Currently, reperfusion therapies focus on rescuing neural lineage cells that survive in spite of decreases in cerebral blood flow. However, vascular lineage cells are known to be more resistant to ischemia/hypoxia than neural lineage cells. This indicates that ischemic areas of the brain experience neural cell death but without vascular cell death. Emerging evidence suggests that if a vascular cell-mediated healing system is present within ischemic areas following reperfusion, the therapeutic time window can be extended for patients with stroke. In this review, we present our comments on this subject based upon recent findings from lethal ischemia following reperfusion in a mouse model of stroke.

Identifiants

pubmed: 32887241
pii: ijms21176360
doi: 10.3390/ijms21176360
pmc: PMC7504064
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

AJNR Am J Neuroradiol. 2005 Apr;26(4):880-4
pubmed: 15814938
J Biol Chem. 2003 Apr 18;278(16):14002-12
pubmed: 12584200
J Cereb Blood Flow Metab. 2012 Aug;32(8):1632-42
pubmed: 22617647
Stem Cells Dev. 2017 Jul 15;26(14):1013-1019
pubmed: 28490256
PLoS One. 2012;7(4):e35577
pubmed: 22523602
Int J Mol Sci. 2019 Dec 17;20(24):
pubmed: 31861092
Curr Neurovasc Res. 2014;11(3):254-62
pubmed: 24875486
Int J Mol Sci. 2020 Jun 28;21(13):
pubmed: 32605320
Front Cell Neurosci. 2020 Feb 14;14:27
pubmed: 32116568
PLoS One. 2012;7(6):e37742
pubmed: 22675489
N Engl J Med. 2018 Feb 22;378(8):708-718
pubmed: 29364767
Nat Rev Neurosci. 2017 Jul;18(7):419-434
pubmed: 28515434
Science. 2019 Jul 19;365(6450):
pubmed: 31221773
Stem Cells Dev. 2018 Oct 1;27(19):1322-1338
pubmed: 29999479
Histol Histopathol. 2018 May;33(5):507-521
pubmed: 29205257
J Exp Stroke Transl Med. 2010 Mar;3(1):28-33
pubmed: 20865060
Int J Mol Sci. 2019 Mar 02;20(5):
pubmed: 30832329
Nat Commun. 2016 Jan 27;7:10523
pubmed: 26813496
Nature. 2010 Nov 25;468(7323):557-61
pubmed: 20944627
Front Aging Neurosci. 2014 Sep 18;6:245
pubmed: 25278877
Cells. 2019 Sep 03;8(9):
pubmed: 31484369
Biogerontology. 2013 Dec;14(6):651-62
pubmed: 24057280
Stroke. 1994 Aug;25(8):1658-64; discussion 1664-5
pubmed: 8042219
Front Immunol. 2018 Feb 20;9:294
pubmed: 29515588
J Neurosci Res. 2002 Sep 15;69(6):925-33
pubmed: 12205685
Sci Rep. 2017 Jun 20;7(1):3855
pubmed: 28634350
N Engl J Med. 2018 Aug 16;379(7):611-622
pubmed: 29766770
AJNR Am J Neuroradiol. 2014 Jun;35(6 Suppl):S1-3
pubmed: 24924546
Trends Immunol. 2009 Nov;30(11):547-56
pubmed: 19783480
Prog Neurobiol. 2018 Apr - May;163-164:144-171
pubmed: 28987927
Nat Neurosci. 2019 Jul;22(7):1089-1098
pubmed: 31235908
J Cereb Blood Flow Metab. 2012 Jul;32(7):1207-21
pubmed: 22395208
Stroke. 2012 Nov;43(11):3063-70
pubmed: 22933588
Stroke. 2019 Jul;50(7):1915-1918
pubmed: 31167622
FASEB J. 2020 May;34(5):7178-7191
pubmed: 32274860
Stem Cells Transl Med. 2019 Mar;8(3):215-224
pubmed: 30592390
Mol Neurobiol. 2020 Feb;57(2):1281-1290
pubmed: 31713815
Front Aging Neurosci. 2018 Jul 19;10:219
pubmed: 30072889
Circ Res. 1997 Dec;81(6):922-31
pubmed: 9400372
AJNR Am J Neuroradiol. 2014 Jun;35(6 Suppl):S37-43
pubmed: 24722308
AJNR Am J Neuroradiol. 2015 Feb;36(2):283-8
pubmed: 25273536
J Clin Invest. 2018 Jan 2;128(1):54-63
pubmed: 29293094
Stroke. 2012 Apr;43(4):1052-7
pubmed: 22363057
J Neurosci. 2006 Mar 29;26(13):3377-89
pubmed: 16571744
Front Neurol Neurosci. 2015;37:62-77
pubmed: 26587772
Stem Cells Dev. 2020 Aug 1;29(15):994-1006
pubmed: 32515302
Biomed Res Int. 2014;2014:297241
pubmed: 25089266
AJNR Am J Neuroradiol. 2013 Jun-Jul;34(6):1113-23
pubmed: 22859287
Nature. 2014 Apr 3;508(7494):55-60
pubmed: 24670647
Int J Mol Sci. 2020 May 30;21(11):
pubmed: 32486305
Exp Dermatol. 2018 Sep;27(9):950-958
pubmed: 29742295
Cells. 2020 Jun 01;9(6):
pubmed: 32492968
Stem Cells Dev. 2011 Dec;20(12):2037-51
pubmed: 21838536
Nat Commun. 2013;4:2932
pubmed: 24336108
J Leukoc Biol. 2013 Jun;93(6):875-81
pubmed: 23505314
Stroke. 2012 Sep;43(9):2362-8
pubmed: 22811456
Cell. 2018 Mar 22;173(1):153-165.e22
pubmed: 29502968
Brain Res. 2016 Jan 1;1630:98-108
pubmed: 26569132
Acta Neuropathol. 2014 Sep;128(3):381-96
pubmed: 24848101
Brain Res Dev Brain Res. 1999 Nov 18;117(2):145-52
pubmed: 10567732
Transl Stroke Res. 2017 Apr;8(2):131-143
pubmed: 27352866
Int J Mol Sci. 2020 Mar 13;21(6):
pubmed: 32183204
Front Aging Neurosci. 2020 Apr 14;12:80
pubmed: 32317958
Gerontology. 2008;54(1):6-17
pubmed: 18160818
Stem Cells Dev. 2016 Dec 15;25(24):1843-1852
pubmed: 27702398
Front Neurosci. 2019 Oct 04;13:1055
pubmed: 31636534
Stroke. 2018 Feb;49(2):384-390
pubmed: 29301970
Sci Rep. 2017 Nov 23;7(1):16163
pubmed: 29170410
World J Stem Cells. 2019 Aug 26;11(8):452-463
pubmed: 31523366
Curr Neurovasc Res. 2012 Feb;9(1):1-9
pubmed: 22272762
Stem Cells. 2009 Sep;27(9):2185-95
pubmed: 19557831
Cell Rep. 2017 Mar 21;18(12):2991-3004
pubmed: 28329690
World J Stem Cells. 2014 Apr 26;6(2):134-43
pubmed: 24772240
N Engl J Med. 2018 Jan 4;378(1):11-21
pubmed: 29129157
Neurosci Res. 2013 Jul;76(3):163-8
pubmed: 23603509
Exp Neurol. 2015 Feb;264:127-34
pubmed: 25510317
Exp Neurol. 2018 Feb;300:13-21
pubmed: 29106980
Stem Cells Dev. 2017 Jun 1;26(11):787-797
pubmed: 28323540
Transl Stroke Res. 2018 Apr;9(2):93-95
pubmed: 28849548
Stem Cells. 2010 Jul;28(7):1292-302
pubmed: 20517983
Stroke. 2020 May;51(5):1458-1463
pubmed: 32295504
Pharmacol Rep. 2018 Oct;70(5):881-884
pubmed: 30096486
J Exp Med. 2012 Jun 4;209(6):1219-34
pubmed: 22615129
Stroke. 2017 Aug;48(8):2222-2230
pubmed: 28626056
Wound Repair Regen. 2016 Mar;24(2):204-14
pubmed: 26969517
Neurosurgery. 2018 Jun 1;82(6):770-780
pubmed: 28973554
Stem Cells. 2015 Jun;33(6):1962-74
pubmed: 25694098
Int J Mol Sci. 2019 Jul 27;20(15):
pubmed: 31357597
J Cereb Blood Flow Metab. 2015 Jun;35(6):888-901
pubmed: 25806703
Brain. 2006 Sep;129(Pt 9):2394-403
pubmed: 16891321
eNeuro. 2020 Mar 11;7(2):
pubmed: 32046974
Int J Mol Sci. 2020 Jan 30;21(3):
pubmed: 32019137
Stem Cell Reports. 2017 Dec 12;9(6):1735-1744
pubmed: 29173896
Am J Physiol Cell Physiol. 2018 Sep 1;315(3):C343-C356
pubmed: 29949404
J Neuroinflammation. 2016 Mar 07;13(1):57
pubmed: 26952098
Int J Mol Sci. 2017 May 24;18(6):
pubmed: 28538706
Stem Cells Dev. 2015 Aug 1;24(15):1730-9
pubmed: 25900222
Interv Neurol. 2018 Oct;7(6):370-377
pubmed: 30410514
Curr Neurovasc Res. 2006 Feb;3(1):3-13
pubmed: 16472121
Stem Cells Dev. 2016 Aug 22;25(20):1549-1558
pubmed: 27549576
Gerontology. 2003 Nov-Dec;49(6):356-65
pubmed: 14624064
Stroke. 2016 Sep;47(9):2405-8
pubmed: 27462115
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852
J Cereb Blood Flow Metab. 2014 Feb;34(2):185-99
pubmed: 24281743
Science. 2011 Jul 8;333(6039):238-42
pubmed: 21737741
JCI Insight. 2017 Feb 9;2(3):e90905
pubmed: 28194443
Brain Pathol. 2013 May;23(3):303-10
pubmed: 23126372
Pharmacol Ther. 2018 Apr;184:131-144
pubmed: 29128343
Stem Cells Dev. 2019 Apr 15;28(8):528-542
pubmed: 30767605
N Engl J Med. 2008 Sep 25;359(13):1317-29
pubmed: 18815396
Eur J Neurosci. 2009 May;29(9):1842-52
pubmed: 19473237
Stem Cell Res Ther. 2019 Jan 25;10(1):46
pubmed: 30683144
Transl Stroke Res. 2017 Dec;8(6):515-528
pubmed: 28744717
J Neuroimaging. 2015 Nov-Dec;25(6):959-63
pubmed: 25702824

Auteurs

Takayuki Nakagomi (T)

Institute for Advanced Medical Sciences, Hyogo College of Medicine, 1-1 Mukogawacho, Nishinomiya 663-8501, Japan.
Department of Therapeutic Progress in Brain Diseases, Hyogo College of Medicine, 1-1 Mukogawacho, Nishinomiya 663-8501, Japan.

Yasue Tanaka (Y)

Department of Neurosurgery, Hyogo College of Medicine, 1-1 Mukogawacho, Nishinomiya 663-8501, Japan.

Nami Nakagomi (N)

Department of Surgical Pathology, Hyogo College of Medicine, 1-1 Mukogawacho, Nishinomiya 663-8501, Japan.

Tomohiro Matsuyama (T)

Department of Therapeutic Progress in Brain Diseases, Hyogo College of Medicine, 1-1 Mukogawacho, Nishinomiya 663-8501, Japan.

Shinichi Yoshimura (S)

Institute for Advanced Medical Sciences, Hyogo College of Medicine, 1-1 Mukogawacho, Nishinomiya 663-8501, Japan.
Department of Neurosurgery, Hyogo College of Medicine, 1-1 Mukogawacho, Nishinomiya 663-8501, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH